FDA Approves Darzalex Faspro for Treating Multiple Myeloma
The quadruplet regimen was approved for stem cell transplant-eligible patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
The quadruplet regimen was approved for stem cell transplant-eligible patients
Only registered members have full access to PracticeUpdate content.